Cystatin C emerged as a better biomarker than serum creatinine as eGFR calculated from Cystatin C was above CKD stage 1 more consistently for all those that had an increased ACR, proteinuria or hypertension which are markers of abnormal kidney function [12]. This evidence concerns the gene CST3 and chronic kidney disease.